Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neurofibromatosis 1 3Warts 1Recurrence 1Port-Wine Stain 1Periodontitis 1Neurofibromatoses 1Lymphoma, Follicular 1Leukoplakia 1Laryngeal Neoplasms 1Hemangioma, Capillary 1Chronic Periodontitis 1Carcinoma 1

Interventions

Timolol 7Propranolol 7Lasers, Dye 3Population Groups 2Nadolol 2Imiquimod 2Atenolol 2ziprasidone 1propranolol mustard 1Zolpidem 1Warfarin 1Vecuronium Bromide 1Vancomycin 1Ultrasonography 1Tranexamic Acid 1Tobramycin 1Surgery, Computer-Assisted 1Spironolactone 1Sevelamer 1Rocuronium 1Piperacillin, Tazobactam Drug Combination 1Pentobarbital 1Oxycodone 1Ophthalmic Solutions 1Ointments 1Nifedipine 1Nafcillin 1Mupirocin 1Molindone 1Methylprednisolone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hemangioma, Capillary × Lasers, Solid-State × Clear all
NCT07183644 2025-09-19

Maximizing Laser Therapy Success for Port-Wine Birthmarks in Pediatric Patients

University of Texas Southwestern Medical Center

Phase NA Not yet recruiting
200 enrolled

Hemangioma, Capillary, Port-Wine Stain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡